EVFM
Evofem Biosciences Inc

17,918
Mkt Cap
$1.2M
Volume
0.00
52W High
$0.016
52W Low
$0.0061
PE Ratio
-0.15
EVFM Fundamentals
50D MA
$0.0115
Beta
0.08
Avg. Volume
750,485.19
EPS (Annual)
-$0.1192
P/B
-0.02
Rev/Employee
$605,093.75
Loading...
Loading...
News
all
press releases
News Placeholder
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
Aditxt and Evofem file for stockholder approval to finalize their merger in Q4 2024. The acquisition will position Evofem as a wholly owned Aditxt subsidiary, enhancing their women’s health portfolio.
Sponsored·1y ago

Latest EVFM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.